A  ||| S:0 E:2 ||| DT
case  ||| S:2 E:7 ||| NN
of  ||| S:7 E:10 ||| IN
an  ||| S:10 E:13 ||| DT
end-of-life  ||| S:13 E:25 ||| JJ
cancer  ||| S:25 E:32 ||| NN
patient  ||| S:32 E:40 ||| NN
in  ||| S:40 E:43 ||| IN
which  ||| S:43 E:49 ||| WDT
lymphedema  ||| S:49 E:60 ||| JJ
care  ||| S:60 E:65 ||| NN
improved  ||| S:65 E:74 ||| VBD
the  ||| S:74 E:78 ||| DT
QOL  ||| S:78 E:82 ||| NNP
enabling  ||| S:82 E:91 ||| VBG
home  ||| S:91 E:96 ||| NN
hospice  ||| S:96 E:104 ||| NNS
care  ||| S:104 E:109 ||| VBP
Recently ||| S:109 E:117 ||| RB
,  ||| S:117 E:119 ||| ,
the  ||| S:119 E:123 ||| DT
importance  ||| S:123 E:134 ||| NN
of  ||| S:134 E:137 ||| IN
prevention  ||| S:137 E:148 ||| NN
and  ||| S:148 E:152 ||| CC
care  ||| S:152 E:157 ||| NN
of  ||| S:157 E:160 ||| IN
lymphedema  ||| S:160 E:171 ||| NN
has  ||| S:171 E:175 ||| VBZ
been  ||| S:175 E:180 ||| VBN
recognized ||| S:180 E:190 ||| VBN
.  ||| S:190 E:192 ||| .
It  ||| S:192 E:195 ||| PRP
appears  ||| S:195 E:203 ||| VBZ
that  ||| S:203 E:208 ||| IN
the  ||| S:208 E:212 ||| DT
complex  ||| S:212 E:220 ||| JJ
physical  ||| S:220 E:229 ||| JJ
therapy  ||| S:229 E:237 ||| NN
is  ||| S:237 E:240 ||| VBZ
relatively  ||| S:240 E:251 ||| RB
taboo  ||| S:251 E:257 ||| VB
for  ||| S:257 E:261 ||| IN
an  ||| S:261 E:264 ||| DT
end-of-life  ||| S:264 E:276 ||| JJ
cancer  ||| S:276 E:283 ||| NN
patient  ||| S:283 E:291 ||| NN
with  ||| S:291 E:296 ||| IN
lymphedema ||| S:296 E:306 ||| NN
.  ||| S:306 E:308 ||| .
Therefore ||| S:308 E:317 ||| RB
,  ||| S:317 E:319 ||| ,
an  ||| S:319 E:322 ||| DT
intervention  ||| S:322 E:335 ||| NN
of  ||| S:335 E:338 ||| IN
care  ||| S:338 E:343 ||| NN
is  ||| S:343 E:346 ||| VBZ
often  ||| S:346 E:352 ||| RB
difficult ||| S:352 E:361 ||| JJ
.  ||| S:361 E:363 ||| .
In  ||| S:363 E:366 ||| IN
our  ||| S:366 E:370 ||| PRP$
case ||| S:370 E:374 ||| NN
,  ||| S:374 E:376 ||| ,
the  ||| S:376 E:380 ||| DT
patient  ||| S:380 E:388 ||| NN
strongly  ||| S:388 E:397 ||| RB
desired  ||| S:397 E:405 ||| VBN
a  ||| S:405 E:407 ||| DT
hospice  ||| S:407 E:415 ||| JJ
care  ||| S:415 E:420 ||| NN
at  ||| S:420 E:423 ||| IN
home ||| S:423 E:427 ||| NN
,  ||| S:427 E:429 ||| ,
so  ||| S:429 E:432 ||| RB
we  ||| S:432 E:435 ||| PRP
introduced  ||| S:435 E:446 ||| VBD
a  ||| S:446 E:448 ||| DT
home  ||| S:448 E:453 ||| NN
hospice  ||| S:453 E:461 ||| NNS
care  ||| S:461 E:466 ||| VBP
gradually  ||| S:466 E:476 ||| RB
taking  ||| S:476 E:483 ||| VBG
a  ||| S:483 E:485 ||| DT
step  ||| S:485 E:490 ||| NN
by  ||| S:490 E:493 ||| IN
step  ||| S:493 E:498 ||| NN
approach  ||| S:498 E:507 ||| NN
with  ||| S:507 E:512 ||| IN
anticipated  ||| S:512 E:524 ||| JJ
harmful  ||| S:524 E:532 ||| JJ
symptoms ||| S:532 E:540 ||| NNS
.  ||| S:540 E:542 ||| .
As  ||| S:542 E:545 ||| IN
a  ||| S:545 E:547 ||| DT
result ||| S:547 E:553 ||| NN
,  ||| S:553 E:555 ||| ,
the  ||| S:555 E:559 ||| DT
home  ||| S:559 E:564 ||| NN
hospice  ||| S:564 E:572 ||| NN
care  ||| S:572 E:577 ||| NN
was  ||| S:577 E:581 ||| VBD
doable  ||| S:581 E:588 ||| VBN
with  ||| S:588 E:593 ||| IN
ADL  ||| S:593 E:597 ||| NNP
and  ||| S:597 E:601 ||| CC
QOL  ||| S:601 E:605 ||| NNP
improvements ||| S:605 E:617 ||| NNS
.  ||| S:617 E:619 ||| .
For  ||| S:619 E:623 ||| IN
lymphedema  ||| S:623 E:634 ||| JJ
care  ||| S:634 E:639 ||| NN
of  ||| S:639 E:642 ||| IN
an  ||| S:642 E:645 ||| DT
end-of-life  ||| S:645 E:657 ||| JJ
cancer  ||| S:657 E:664 ||| NN
patient ||| S:664 E:671 ||| NN
,  ||| S:671 E:673 ||| ,
a  ||| S:673 E:675 ||| DT
goal  ||| S:675 E:680 ||| NN
setting ||| S:680 E:687 ||| NN
,  ||| S:687 E:689 ||| ,
sharing  ||| S:689 E:697 ||| VBG
the  ||| S:697 E:701 ||| DT
patient ||| S:701 E:708 ||| NN
's  ||| S:708 E:711 ||| POS
will  ||| S:711 E:716 ||| NN
based  ||| S:716 E:722 ||| VBN
on  ||| S:722 E:725 ||| IN
anticipated  ||| S:725 E:737 ||| JJ
symptoms ||| S:737 E:745 ||| NNS
,  ||| S:745 E:747 ||| ,
and  ||| S:747 E:751 ||| CC
an  ||| S:751 E:754 ||| DT
introduction  ||| S:754 E:767 ||| NN
of  ||| S:767 E:770 ||| IN
a  ||| S:770 E:772 ||| DT
gradual  ||| S:772 E:780 ||| JJ
care  ||| S:780 E:785 ||| NN
were  ||| S:785 E:790 ||| VBD
all  ||| S:790 E:794 ||| DT
important ||| S:794 E:803 ||| JJ
.  ||| S:803 E:805 ||| .
